期刊
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
卷 20, 期 3, 页码 329-345出版社
IVYSPRING INT PUBL
DOI: 10.7150/ijms.80358
关键词
Familial idiopathic pulmonary fibrosis; Sporadic idiopathic pulmonary fibrosis; Telomerase-associated gene; Mucin 5B; Surfactant-related gene
This article systematically summarizes the genetic mechanisms of familial idiopathic pulmonary fibrosis (f-IPF), revealing the genetic variations and susceptibility related to the disease. It contributes to a better understanding of IPF pathogenesis and facilitates early detection.
Idiopathic pulmonary fibrosis (IPF) is a severe interstitial lung disease; although the recent introduction of two anti-fibrosis drugs, pirfenidone and Nidanib, have resulted in a significant reduction in lung function decline, IPF is still not curable. Approximately 2-20% of patients with IPF have a family history of the disease, which is considered the strongest risk factor for idiopathic interstitial pneumonia. However, the genetic predispositions of familial IPF (f-IPF), a particular type of IPF, remain largely unknown. Genetics affect the susceptibility and progression of f-IPF. Genomic markers are increasingly being recognized for their contribution to disease prognosis and drug therapy outcomes. Existing data suggest that genomics may help identify individuals at risk for f-IPF, accurately classify patients, elucidate key pathways involved in disease pathogenesis, and ultimately develop more effective targeted therapies. Since several genetic variants associated with the disease have been found in f-IPF, this review systematically summarizes the latest progress in the gene spectrum of the f-IPF population and the underlying mechanisms of f-IPF. The genetic susceptibility variation related to the disease phenotype is also illustrated. This review aims to improve the understanding of the IPF pathogenesis and facilitate his early detection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据